Brief: Inari Medical Q3 Revenue USD 153.39 Million Vs. IBES Estimate USD 150.7 Million
28/10/2024 20:05
Oct 28 (Reuters) - Inari Medical Q3 net income USD -18.367 million vs. IBES estimate USD -7.5 million. * Q3 income from operations USD -13.568 million vs. IBES estimate USD -8.11 million * Q3 pretax profit USD -12.672 million vs. IBES estimate USD -8.11 million * Q3 gross profit USD 133.544 million * outlook FY revenue USD 601.5-604.5 million
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty